
Meilleure Health International Industry Group Limited
2327.HKHKSEIndustrialsConglomerates
Latest quote
HK$0.242
+HK$0.002 · +0.83%
2327.HK company overview
Historical prices · Market data may be delayed.
Company profile
Company websiteMeilleure Health International Industry Group Limited functions as an investment holding company, overseeing a broad spectrum of ventures in Hong Kong, the People's Republic of China, and other international markets. Its diverse operations include industrial hemp, healthcare-related services, trading, various agency services, and both property investment/leasing and development. The company actively engages in the commerce of construction supplies, the creation and sale of residential real estate, property asset management, and the distribution of health-related goods. Furthermore, it provides real estate brokerage, services focused on the application of cannabidiol (CBD) derivatives, and comprehensive health management offerings, such as anti-aging treatments, aesthetic medicine, and general wellness consulting. It also acts as an agent for healthcare product sales. Formerly known as U-Home Group Holdings Limited, the company rebranded to Meilleure Health International Industry Group Limited in March 2017. Its primary corporate office is located in Admiralty, Hong Kong.
- Industry
- Conglomerates
- Sector
- Industrials
- Headquarters
- HK
- CEO
- Wen Chuan Zhou
- Listed since
- Oct 14, 2003
- Employees
- 42
Market position
Day range
Current HK$0.242
52-week range
Current HK$0.242
- Open
- HK$0.239
- Previous close
- HK$0.24
- Volume
- 60K
- 0.18× average
- Average volume
- 329.9K
- Average daily volume
- Market cap
- 981.4M HKD
- Beta
- 0.03
- Market reference 1
- 50-day average
- HK$0.2491
- -2.84% below average
- 200-day average
- HK$0.2648
- -8.61% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 1.44B HKD
- P/E (TTM)
- 26.02×
- P/B (TTM)
- 0.79×
- P/S (TTM)
- 26.87×
- EV / EBITDA
- -160.81×
- Earnings yield
- 3.51%
- Free cash flow yield
- -4.68%
- Dividend yield
- 1.65%
Profitability & efficiency
- Gross margin
- 61.97%
- Operating margin
- -26.59%
- Net margin
- 104.01%
- Return on equity
- 3.04%
- Return on assets
- 2.09%
- Return on invested capital
- -0.43%
Financial health
- Debt / equity
- 0.31×
- Current ratio
- 2.81×
- Altman Z-score
- 1.78
- Piotroski F-score
- 5 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (HKD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 36.52M HKD | 50.68M HKD | 129.3M HKD | 119.89M HKD | 253.03M HKD |
| Cost of goods sold | 13.89M HKD | 21.77M HKD | 51.21M HKD | 53.13M HKD | 152.1M HKD |
| Gross profit | 22.63M HKD | 28.91M HKD | 78.09M HKD | 66.76M HKD | 100.93M HKD |
| Selling, general, and administrative | 31.17M HKD | 31.6M HKD | 39.34M HKD | 35.69M HKD | 42.66M HKD |
| Operating expenses | 32.34M HKD | 31.8M HKD | 55.11M HKD | 33.08M HKD | 47.68M HKD |
| Interest income | 29.3M HKD | 22.05M HKD | 18.82M HKD | 26.91M HKD | 12.45M HKD |
| Interest expense | 9.29M HKD | 10.29M HKD | 11.41M HKD | 11.45M HKD | 8.39M HKD |
| Depreciation and amortization | 737K HKD | 1.63M HKD | 2.64M HKD | 3.85M HKD | 3.58M HKD |
| Operating income | −9.71M HKD | −3.85M HKD | 39.36M HKD | 32.24M HKD | 53.25M HKD |
| Net income | 37.98M HKD | 32.48M HKD | 40.83M HKD | 17.82M HKD | 60.32M HKD |
Company facts updated Aug 24, 2026.
2327.HK peers
Continue in GoAI
Research 2327.HKresearch.disclaimer





